發(fā)布時(shí)間：2018-10-23 12:58

【摘要】：目的探討放射線誘導(dǎo)的乳腺癌1號(hào)基因(BRCA1)出核效應(yīng)對(duì)同源重組介導(dǎo)的DNA雙鏈斷裂損傷(DSB)修復(fù)功能的影響及對(duì)聚腺苷二磷酸核糖聚合酶(PARP)抑制劑的增敏作用。方法采用亞細(xì)胞純化及蛋白印跡法檢測(cè)乳腺癌細(xì)胞株MCF7經(jīng)放射線處理后BRCA1的亞細(xì)胞定位,同時(shí)采用免疫熒光法檢測(cè)細(xì)胞核磷酸化的H2AX組蛋白(γ-H2AX)、Rad51核焦點(diǎn)形成。流式細(xì)胞技術(shù)檢測(cè)細(xì)胞凋亡、克隆形成實(shí)驗(yàn)檢測(cè)體外細(xì)胞存活情況,并制作裸鼠皮下移植瘤模型,分為4組,分別為:對(duì)照組、放射+DMSO組、假照+ABT-888(ABT-888為PARP抑制劑)組、放射+ABT-888組,每5 d為1個(gè)治療周期,周期第1天給予2 Gy照射或假照射。第2~5天給予溶劑(對(duì)照組、放射+DMSO組)或20 mg/(kg·d)的ABT-888(假照+ABT-888組),總共給予4個(gè)周期的治療。檢測(cè)各組的體內(nèi)抑瘤作用。結(jié)果經(jīng)4 Gy放射處理后,MCF7胞核BRCA1表達(dá)量減少,僅為對(duì)照組的41%,但胞漿內(nèi)表達(dá)量明顯增多,是對(duì)照組的2.14倍(P0.01);同時(shí)MCF7細(xì)胞經(jīng)4 Gy放射處理后ABT-888誘導(dǎo)的Rad51核焦點(diǎn)形成陽(yáng)性細(xì)胞也較對(duì)照組明顯減少(7%vs.30%,P=0.01)。放射線和ABT-888聯(lián)合應(yīng)用導(dǎo)致MCF7細(xì)胞凋亡率增高(19%),與對(duì)照組(5%)、放射+DMSO組(9%)或假照+ABT-888組(6.2%)相比較差異有統(tǒng)計(jì)學(xué)意義(P0.01)。裸鼠移植瘤模型中放射+ABT-888組對(duì)腫瘤生長(zhǎng)抑制作用明顯優(yōu)于假照+DMSO組或假照+ABT-888組(P0.01)。結(jié)論放射線可誘導(dǎo)BRCA1出核并增強(qiáng)PARP抑制劑的抗腫瘤作用。
[Abstract]:Objective to investigate the effect of radiation-induced nucleation of breast cancer gene 1 (BRCA1) on the repair function of (DSB) induced by homologous recombination of DNA double strand break and to enhance the sensitivity of polyadenosine diphosphate ribose polymerase (PARP) inhibitor. Methods the subcellular localization of BRCA1 in breast cancer cell line MCF7 was detected by subcellular purification and Western blotting. Meanwhile, nuclear phosphorylation of H2AX histone (緯-H2AX) and nuclear focus formation of Rad51 were detected by immunofluorescence. Flow cytometry was used to detect cell apoptosis and clone formation assay was used to detect cell survival in vitro. The nude mice were divided into 4 groups: control group, radiation DMSO group, pseudoradiographic ABT-888 (ABT-888 as PARP inhibitor) group. ABT-888 group was given 2 Gy irradiation or false irradiation every 5 days. A total of 4 cycles of treatment were given on day 2 to day 5: solvent (control group, radiation DMSO group) or 20 mg/ (kg d) ABT-888 (pseudoradiographic ABT-888 group). The inhibitory effect in vivo of each group was detected. Results after 4 Gy irradiation, the expression of BRCA1 in the nucleus of MCF7 was decreased to 41% of that in the control group, but the expression of BRCA1 in the cytoplasm was significantly increased. At the same time, the number of Rad51 focus forming positive cells induced by ABT-888 in MCF7 cells after 4 Gy irradiation was significantly lower than that in the control group (7vs.30). The apoptosis rate of MCF7 cells was increased by radiation combined with ABT-888 (19%), which was significantly higher than that of control group (5%), radiation DMSO group (9%) or pseudoradiographic ABT-888 group (6.2%) (P0.01). In nude mice, the inhibitory effect of radiation ABT-888 on tumor growth was significantly better than that of DMSO or ABT-888 (P0.01). Conclusion radiation can induce the nucleation of BRCA1 and enhance the anti-tumor effect of PARP inhibitor.
【作者單位】： 廣州醫(yī)科大學(xué)附屬第一醫(yī)院呼吸疾病國(guó)家重點(diǎn)實(shí)驗(yàn)室 廣州呼吸疾病研究所;廣州醫(yī)科大學(xué)附屬第一醫(yī)院病理科;
【基金】：國(guó)家自然科學(xué)基金資助項(xiàng)目(編號(hào):81272901) 廣州市醫(yī)藥衛(wèi)生科技項(xiàng)目(編號(hào):20151A011067)
【分類號(hào)】：R737.9

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 周冬仙;熊文;徐紅先;邵超鵬;;A Novel Frequent BRCA1 Allele in Chinese Patients with Breast Cancer[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)英德文版);2006年05期

2 任婕;魏敏杰;金鋒;楊棟;林哲珠;馬文峰;金萬(wàn)寶;;散發(fā)性乳腺癌組織中BRCA1基因啟動(dòng)子甲基化與蛋白表達(dá)的相關(guān)性[J];中華腫瘤防治雜志;2007年03期

3 Rajasekaran R;George Priya Doss;Sudandiradoss C;Ramanathan K;Rituraj Purohit;Rao Sethumadhavan;;Computational and Structural Investigation of Deleterious Functional SNPs in Breast Cancer BRCA2 Gene[J];生物工程學(xué)報(bào);2008年05期

4 任婕;王麟;馬文峰;米小軼;馮婉玉;金萬(wàn)寶;魏敏杰;;BRCA1和相關(guān)凋亡調(diào)控蛋白在人乳腺浸潤(rùn)性導(dǎo)管癌中的表達(dá)與相關(guān)性分析[J];現(xiàn)代腫瘤醫(yī)學(xué);2008年08期

5 易韋;文安智;;BRCA_1在散發(fā)性乳腺浸潤(rùn)性導(dǎo)管癌癌組織中的表達(dá)及意義[J];山東醫(yī)藥;2008年26期

6 董蕾;李文才;;人BRCA1真核表達(dá)載體的構(gòu)建及鑒定[J];山東醫(yī)藥;2009年51期

7 王辛;熊靜波;黎相照;褚紅娟;張弓;楊建芳;趙彤;;散發(fā)性乳腺浸潤(rùn)性導(dǎo)管癌中BRCA1表達(dá)及臨床意義[J];中國(guó)腫瘤臨床;2009年02期

8 張永平;趙虎;韋伊芳;張健;藥立波;;人BRCA1干涉慢病毒載體的構(gòu)建與驗(yàn)證[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年17期

9 范q，

本文編號(hào)：2289315